文献速递临床试验与 GCP

针对镰状细胞病患者的电话正念干预:随机对照试验研究方案

A telephonic mindfulness-based intervention for persons with sickle cell disease: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-05-15

本研究为随机对照试验方案,计划在美国东南部一家门诊综合性镰状细胞病中心纳入60例伴有慢性疼痛的成人镰状细胞病患者,随机分配至正念干预组或等待名单对照组。正念干预组完成六次每次60分钟的电话团体正念干预,在基线和第1、3、6周通过问卷评估可行性、可接受性及对疼痛灾难化的初步疗效,并随机选取10名正念干预参与者进行半结构化访谈。

要点

  • 研究纳入60例伴有慢性疼痛的成人镰状细胞病患者,随机分为正念干预组与等待名单对照组。
  • 正念干预组接受六次、每次60分钟的电话团体正念干预。
  • 在基线和第1、3、6周评估可行性、可接受性及对疼痛灾难化的初步疗效。

核心结论

  • 本研究的发现将有助于确定正念干预对镰状细胞病伴慢性疼痛患者的可接受性、可行性和疗效。

研究设计与样本

  • 本研究为随机对照试验,计划在美国东南部一家门诊综合性镰状细胞病中心纳入60例伴有慢性疼痛的成人镰状细胞病患者。
  • 患者随机分配至正念干预组或等待名单对照组。
  • 正念干预组完成六次、每次60分钟的电话团体正念干预。

主要发现

  • 在基线和第1、3、6周通过问卷评估正念干预对疼痛灾难化的可行性、可接受性和疗效。
  • 随机选取10名正念干预参与者完成半结构化访谈,以帮助确定干预的可接受性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: One of the most difficult symptoms for persons with sickle cell disease (SCD) to manage is chronic pain. Chronic pain impacts approximately one-third of persons with SCD and is associated with increased pain intensity, pain behavior, and frequency and duration of hospital visits. A promising category of nonpharmacological interventions for managing both physical and affective components of pain are mindfulness-based interventions (MBIs). METHODS/DESIGN: The primary aim of this study is to conduct a randomized controlled study to evaluate the acceptability and feasibility, as well as to determine the preliminary efficacy, of a telephonic MBI for adults with SCD who have chronic pain. We will enroll 60 adult patients with SCD and chronic pain at an outpatient comprehensive SCD center in the southeastern United States. Patients will be randomized to either an MBI or a wait-listed control group. The MBI group will complete a six-session (60 minutes), telephonically delivered, group-based MBI program. The feasibility, acceptability, and efficacy of the MBI regarding pain catastrophizing will be assessed by administering questionnaires at baseline and weeks 1, 3, and 6. In addition, ten randomly selected MBI participants will complete semistructured interviews to help determine intervention acceptability. DISCUSSION: In this study protocol, we report detailed methods of the randomized controlled trial. Findings of this study will be useful to determine the acceptability, feasibility, and efficacy of an MBI for persons with SCD and chronic pain. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02394587 . Registered on 9 February 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Williams H, Silva S, Simmons LA, et al. A telephonic mindfulness-based intervention for persons with sickle cell disease: study protocol for a randomized controlled trial. Trials. 2017. PMID: 28506281. doi:10.1186/s13063-017-1948-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。